xanthine and linagliptin

xanthine has been researched along with linagliptin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deacon, CF; Holst, JJ	1

Reviews

1 review(s) available for xanthine and linagliptin

Article	Year
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:1 Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Linagliptin; Molecular Structure; Purines; Quinazolines; Xanthine	2010

Article

Year

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes.

Expert opinion on investigational drugs, 2010, Volume: 19, Issue:1

Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Linagliptin; Molecular Structure; Purines; Quinazolines; Xanthine

2010